Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Diethelm Messinger"'
Autor:
Christophe Le Tourneau, Massimo Ghiani, Maria Chiara Cau, Roberta Depenni, Graziana Ronzino, Pierluigi Bonomo, Vincenzo Montesarchio, Luigi Leo, Jeltje Schulten, Satu Salmio, Diethelm Messinger, Andrea Sbrana, Edith Borcoman, Maria Grazia Ghi
Publikováno v:
Cancer Reports, Vol 6, Iss 5, Pp n/a-n/a (2023)
Abstract Background ENCORE, an observational, prospective, open‐label study, investigated real‐world treatment practices and outcomes with cetuximab plus platinum‐based therapy (PBT) in first‐line (1L) recurrent and/or metastatic squamous cel
Externí odkaz:
https://doaj.org/article/2aac3541984b4cb79407e47c1b6ba1ae
Autor:
Markus Hecht, Dennis Hahn, Philipp Wolber, Matthias G. Hautmann, Dietmar Reichert, Steffi Weniger, Claus Belka, Tobias Bergmann, Thomas Göhler, Manfred Welslau, Christina Große-Thie, Orlando Guntinas-Lichius, Jens von der Grün, Panagiotis Balermpas, Katrin Orlowski, Diethelm Messinger, Karsten G. Stenzel, Rainer Fietkau
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Head and neck squamous cell cancer (HNSCC) frequently causes severe symptoms that may be reduced, when the tumor is successfully treated. The SOCCER trial studied the association of treatment response with patient reported tumor s
Externí odkaz:
https://doaj.org/article/b0e785e23cee4e3ebc4a8def0086024d
Autor:
Patrick Marcellin, Qing Xie, Seung Woon Paik, Robert Flisiak, Teerha Piratvisuth, Jörg Petersen, Tarik Asselah, Markus Cornberg, Denis Ouzan, Graham R Foster, Georgios Papatheodoridis, Diethelm Messinger, Loredana Regep, Georgios Bakalos, Ulrich Alshuth, Pietro Lampertico, Heiner Wedemeyer
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230893 (2020)
BACKGROUND AND AIMS:Sustained off-treatment immune control is achievable in a proportion of patients with chronic hepatitis B treated with peginterferon alfa-2a. We evaluated on-treatment predictors of hepatitis B surface antigen (HBsAg) clearance 3
Externí odkaz:
https://doaj.org/article/649c053409174c06937ec675c2be6fb1
Autor:
Tarik Asselah, Alex J Thompson, Robert Flisiak, Manuel Romero-Gomez, Diethelm Messinger, Georgios Bakalos, Mitchell L Shiffman
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150569 (2016)
BACKGROUND:Access to direct-acting antiviral agents (DAAs) is restricted in some settings; thus, the European Association for the Study of the Liver recommends dual peginterferon/ribavirin (PegIFN/RBV) therapy wherever DAAs are unavailable. HCV genot
Externí odkaz:
https://doaj.org/article/750a84bb92f346559fb24e1a98ea8517
Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia.
Autor:
Evelyn Klein, Dietmar Schlembach, Angela Ramoni, Elena Langer, Franz Bahlmann, Sabine Grill, Helene Schaffenrath, Reinhard van der Does, Diethelm Messinger, Wilma D J Verhagen-Kamerbeek, Manfred Reim, Martin Hund, Holger Stepan
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0156013 (2016)
OBJECTIVE:To evaluate the influence of the soluble fms-like tyrosine kinase 1/placental growth factor ratio in physicians' decision making in pregnant women with signs and symptoms of preeclampsia in routine clinical practice. METHODS:A multicenter,
Externí odkaz:
https://doaj.org/article/d3a0839e15f947a490c04d00828c5a26
Autor:
Christophe Le Tourneau, Massimo Ghiani, Maria Chiara Cau, Roberta Depenni, Graziana Ronzino, Pierluigi Bonomo, Vincenzo Montesarchio, Luigi Leo, Jeltje Schulten, Satu Salmio, Diethelm Messinger, Andrea Sbrana, Edith Borcoman, Maria Grazia Ghi
Publikováno v:
Cancer Reports. 6
Autor:
Friedrich Stolzl, S. von Harsdorf, Irina Türüchanow, Karin Westphal, Arnold Ganser, Donald Bunjes, Michael Stadler, Gernot Beutel, Armin Papkalla, Danny Jonigk, Steve Ehrlich, Diethelm Messinger, Lothar Hambach, Johannes Schetelig, Heiko von der Leyen, Hans Kreipe, Stefan Klein, Wolfgang Bethge, Iyas Hamwi, Eva M. Weissinger, Eva-Maria Wagner-Drouet, Julia Raad, Jürgen Krauter, Michael Schleuning, Ernst Holler, Herrad Baurmann, Andreas Rank, Jochen Metzger, Christoph Schmid, Daniela Heidenreich, Kerstin Schäfer-Eckart
Publikováno v:
Leukemia
Acute graft-versus-host disease (aGvHD) contributes to about 50% of transplant-related mortality (non-relapse mortality) after allogeneic hematopoietic stem cell transplantation (HSCT). Here the predictive value of a urinary proteomic profile (aGvHD_
Autor:
Christoph C. Zielinski, W. Chen, Stefan Kasper, Caroline Foch, Francois-Xavier Lamy, Regina Esser, Diethelm Messinger, Vivien Rothe, Magali Rouyer, Thomas Brodowicz, Ann-Lii Cheng
Aim This study assessed whether cetuximab 500 mg/m2 administered every 2 weeks (Q2W), when combined with chemotherapy as a first-line (1L) treatment, was noninferior to the approved dose (400 mg/m2 followed by 250 mg/m2 once weekly [Q1W]) for overall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3680e0bbc373927d91757ff577d3e4b
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85098158489
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85098158489
Autor:
Wendelin Schramm, Christopher G. Parkin, Diethelm Messinger, Iris Vesper, Bernhard Kulzer, Joerg Weissmann, Ingrid Daenschel, Lutz Heinemann, Wilfried Daenschel
Publikováno v:
Diabetes Research and Clinical Practice. 144:200-212
Globally, many patients with insulin-treated type-2 diabetes are suboptimally controlled. The PDM-ProValue study program evaluated whether integrated personalized diabetes management (iPDM) has the potential to improve clinical outcomes.101 practices
Autor:
Maurizia Rossana Brunetto, A. Caputo, Pietro Lampertico, Diethelm Messinger, Jörg Petersen, Georgios Bakalos, T Asselah, Markus Cornberg, George V. Papatheodoridis, Rothe, Patrick T F Kennedy, Pavlovic
Publikováno v:
Annals of Gastroenterology
Background Peginterferon alfa-2a induces durable responses in some hepatitis B e antigen-negative patients, but robust pretreatment predictors are not available to identify likely responders. In this study we aimed to develop genotype-specific baseli